Inhibrx Biosciences, Inc.
INBXBiotechnology
$73.65+0.49%As of Oct 29vs prior close
- Market cap
- $1.1B
- P/E (TTM)
- –
- From 52W high
- −48.08%
- EPS (YE25)
- -$9.04
- Revenue (YE25)
- $1.3M
- Net margin
- -10773.46%
- Dividend yield
- 0.00%
Nomior Score
27
Emerging BreakoutSpeculativeBottom 13% of the scored universe
Growth—
Quality17
Value47
Momentum52
Resilience22
Growth
−15.02%revenue a year over 2 fiscal years
YE23 $1.8MYE25 $1.3M
Connections
Revenue to profitYE25
The operating loss was 10387% of revenue, narrower by 155337 pts on a year.
Who owns it
2funds, 1 tracked portfolio